Consolidated Statements of Income (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Mar. 30, 2013	Mar. 31, 2012	Mar. 30, 2013	Mar. 31, 2012
Net sales	$ 919,825	$ 778,017	$ 2,572,594	$ 2,341,482
Cost of sales	588,464	498,744	1,648,799	1,539,755
Gross profit	331,361	279,273	923,795	801,727
Operating expenses
Distribution	12,569	10,181	35,035	29,540
Research and development	28,526	27,950	84,244	78,736
Selling and administration	111,660	87,991	305,480	278,080
Restructuring	0	7,081	0	7,081
Total operating expenses	152,755	133,203	424,759	393,437
Operating income	178,606	146,070	499,036	408,290
Interest, net	16,070	16,651	47,237	44,862
Other expense (income), net	841	(5,202)	855	(4,221)
Losses on sales of investments	1,608	0	4,657	0
Income before income taxes	160,087	134,621	446,287	367,649
Income tax expense	48,163	18,894	122,828	81,725
Net income	$ 111,924	$ 115,727	$ 323,459	$ 285,924
Earnings per share
Basic earnings per share	$ 1.19	$ 1.24	$ 3.45	$ 3.07
Diluted earnings per share	$ 1.18	$ 1.23	$ 3.42	$ 3.04
Weighted average shares outstanding
Basic	93,989	93,330	93,833	93,152
Diluted	94,519	94,124	94,443	94,028
Dividends declared per share	$ 0.09	$ 0.08	$ 0.26	$ 0.23